Can You Get COVID-19 Again? Replay our May 22 HDLive!

Follow Our Live Coverage of COVID-19 Developments

Prevalence of Knee OA Lower With Menopausal Hormone Therapy

Odds ratio for knee osteoarthritis was 0.7 in MHT group versus non-MHT group in multivariable model

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

THURSDAY, Jan. 17, 2019 (HealthDay News) -- For postmenopausal women, the prevalence of knee osteoarthritis is lower with menopausal hormone therapy (MHT) use, according to a study published online Dec. 21 in Menopause.

Jae Hyun Jung, M.D., Ph.D., from the Korea University College of Medicine in Seoul, and colleagues collected data from 4,766 postmenopausal women from the Korea National Health and Nutrition Examination Survey (2009 to 2012). MHT was defined as use of regular hormone medication for one year or more; the correlation between prevalence of knee OA and MHT was examined.

The researchers found that the odds ratio for OA was 0.7 for the MHT group versus the non-MHT group in the multiple logistic regression models.

"This cross-sectional study precludes conclusions about causal relationships, so further prospective studies and intervention trials should be undertaken to establish a causal association between knee OA and MHT," the authors write.

Abstract/Full Text (subscription or payment may be required)

Last Updated: